AN UPDATED ANALYSIS OF ETIOLOGIES AND PROGNOSIS OF 30-DAY READMISSION IN HEART FAILURE
AbstractBackground: The prevalence of Heart Failure (HF) is expected to rise over the next few decades, placing a significant strain on the healthcare system. Exact risk stratification in HF is still difficult, even though numerous prognostic markers of death and/or HF hospitalization have been found in HF patients; nonetheless, their practical usefulness is restricted. Aim and Objective: The current study aimed to determine the etiology of hospitalization and readmission with HF patients, and the factors associated with readmission. Materials and Methods: A prospective-observational study was conducted with 81 HF patients for 3 months. The patient’s data collection form and cash sheets were used to record the patient’s clinical information’s. The collected data were analyzed using the SPSS statistical software. Results: A total of 81 patients were included in this study. The study participants’ median age was 61.5 years, with the majority being male (70.37%). Dyspnea (80.24%) was the most common symptom. HFrEF(86.41%) was the most prevalent type of HF. Type 2 DM (72.83%) was the most common co-morbid condition. There is an inverse correlation between compliance and readmission with a p-value of 0.007. The class of HF was strongly (p=0.043) correlated with readmission. An increased levels of NT proBNP, Troponin T, and HbA1C%, serum urea level, and blood pressure were observed in readmission. Conclusion: The noncompliance, high serum urea, decreased EF, high blood pressure, poorly managed HbA1C, and lack of ACEIs were all significantly associated to HF readmission. The risk of readmission and mortality may be mitigated by focusing on improving medication adherence through patient education and managing co-morbidities.
Article Information
10
3220-3227
616 KB
73
English
IJPSR
Dhandapani Chidambaram, Gokulapriya Kannan *, Kavya Kumaraswamy, Lakshana Thirumoorthi and Saranya Thillai Selvi Kalairaja
Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India.
gokulapriyadr@gmail.com
27 May 2024
24 June 2024
17 July 2024
10.13040/IJPSR.0975-8232.15(11).3220-27
01 November 2024